 |
4 Diseases |  |
0 Trials |
|
0 Trials |  |
2 News |  |
- | Thravixa (AVP-21D9) / Emergent Biosolutions
Trial completion, IO biomarker: Safety and Pharmacokinetics Study of Human Monoclonal Antibody (AVP-21D9) (clinicaltrials.gov) - Feb 20, 2012
P1, N=50, Completed, Sponsor: Emergent BioSolutions
Active, not recruiting --> Completed